| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/20/2007 | WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | WO2007105719A1 Novel substitute material for heparin, and method for production thereof |
| 09/20/2007 | WO2007104317A1 Methods for local treatment with factor vii |
| 09/20/2007 | WO2007014749A3 Regulation of tissue factor activity by protein s and tissue factor pathway inhibitor |
| 09/20/2007 | WO2007008671A3 Methods for treating fus1 related disorders |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219210 Amidopyrazole Derivative |
| 09/20/2007 | US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors |
| 09/20/2007 | US20070218067 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors |
| 09/20/2007 | DE4003844B4 Neue Cyclosporin enthaltende galenische Formulierungen New cyclosporin-containing pharmaceutical formulations |
| 09/20/2007 | CA2680736A1 Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors |
| 09/20/2007 | CA2645810A1 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |
| 09/20/2007 | CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/19/2007 | EP1834652A1 Dialysis preparation |
| 09/19/2007 | EP1834640A2 Kappa opiatagonists for treating bladder diseases |
| 09/19/2007 | EP1833832A1 Napthyridine compounds as rock inhibitors |
| 09/19/2007 | EP1655301A4 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1296982B1 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors |
| 09/19/2007 | EP1263803B1 Embolic compositions |
| 09/19/2007 | EP1192134B1 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol |
| 09/19/2007 | CN101039936A Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 09/19/2007 | CN101039934A 1,5-diheterocycle-1H-triazole derivative |
| 09/19/2007 | CN101037679A Nattokinase purification technique and microcapsule preparation technique |
| 09/19/2007 | CN101037471A Half electric charge matching nonapeptide and application thereof |
| 09/19/2007 | CN101036733A Callicarpa agent for stanching and the method for preparing the same |
| 09/19/2007 | CN101036728A Selenium germanium peptide maggot skin antithrombotic jujube tea powder for curing encephalatrophy radically |
| 09/19/2007 | CN101036726A Myocardial and brain developer and its prepn |
| 09/19/2007 | CN101036715A Method for producing dicatamnus dasycarpus medicine |
| 09/19/2007 | CN101036708A Medicine composition for treatment of cardio-cerebralvascular disease |
| 09/19/2007 | CN101036680A Gynura procumbens troche and method for preparing the same |
| 09/19/2007 | CN101036679A Gynura procumbens chewing gums and the method for preparing the same |
| 09/19/2007 | CN101036646A Quassia wood total alkaloid and the medical function of the monocase alkaloid |
| 09/19/2007 | CN100338093C Flexible container system for storage of stabilized hemoglobin solutions |
| 09/19/2007 | CN100338068C Process for preparing clopidogrel |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 09/19/2007 | CN100337671C Chinese traditional medicine for treating thrombocytopenia |
| 09/19/2007 | CN100337666C Preparation method of compound peach blossom deea tortoise life nourishing agent |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271184 For controlling parasites on warm-blooded animals; veterinary medicine |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271152 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 09/18/2007 | US7271144 Therapeutic fibrin-derived peptides and uses thereof |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | CA2417106C Piperazine derivatives |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/13/2007 | WO2007103996A1 2-(aryloxy)acetamide factor viia inhibitors useful as anticoagulants |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007071850A3 Inhibition of the anti-fviii immune response |
| 09/13/2007 | US20070213800 Method and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
| 09/13/2007 | US20070212743 Assays for Determining Anticoagulant Cofactor Activity |
| 09/13/2007 | US20070212344 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 09/13/2007 | DE19981169B4 Kovalent an Gallensäuren oder Sterine gebundenes Heparin, dessen Verwendung und diese enthaltende pharmazeutische Zusammensetzung Covalently bound to bile acids or sterols heparin, its use and these pharmaceutical composition containing |
| 09/13/2007 | DE102006042615A1 Sicherung der Stabilität von Phytomenadion-haltigen flüssigen Arzneimittelzubereitungen zum Einnehmen mittels Zusatz von 0,01% Natriumedetat Ensuring the stability of phytomenadione-containing liquid pharmaceutical preparations for internal use by the addition of 0.01% sodium edetate |
| 09/13/2007 | CA2680228A1 Modified molecules which promote hematopoiesis |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832297A1 Anticoagulant agents useful in treatment of thrombosis |
| 09/12/2007 | EP1830924A1 Prevention of thrombus formation and/or stabilization |
| 09/12/2007 | EP1830884A1 Treatment of inflammatory diseases |
| 09/12/2007 | EP1830826A2 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | CN101035891A Lecithinized superoxide dismutase composition and process for producing the same |
| 09/12/2007 | CN101035759A Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 09/12/2007 | CN101035594A Food products for diabetics |
| 09/12/2007 | CN101033250A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 09/12/2007 | CN101032618A Chinese traditional medicine for curing late puerperal hemorrhage |
| 09/12/2007 | CN101032584A Chinese traditional medicine composition to be taken orally for curing metropathia hemorrhagica |
| 09/12/2007 | CN101032578A Chinese traditional medicine composition to be taken orally for curing Metropathia Hemorrhagica |
| 09/12/2007 | CN101032575A Chinese traditional medicine for curing angiocardiopathy and cerebrovascular disease |
| 09/12/2007 | CN101032516A Preparing technique of zeolite type quick hemostasis agent |
| 09/12/2007 | CN101032512A Medicine composition for expanding blood volume and the preparing method thereof |
| 09/12/2007 | CN101032485A Application of 21(S) argatroban |
| 09/12/2007 | CN101032270A Preparing method of composite type persimmon leaf tea |
| 09/12/2007 | CN100336903C Extracting norfibroase from snake venom and preparation process for liquid drugs injection of norfibroase |
| 09/12/2007 | CN100336897C Nutrient Songnian wine and its making process |
| 09/12/2007 | CN100336557C Somatostation a aqua prepn and its prepn process and application |
| 09/12/2007 | CN100336554C Chinese herbal plant medicinal oil |
| 09/12/2007 | CN100336545C Medicinal wine with aizoon stonecrop for treating blood vessel disease and its preparation method |
| 09/12/2007 | CN100336504C Beta-Asarone transdermal plaster |
| 09/12/2007 | CN100336502C Yunnan Manyleaf paris Rhizome extract ora disintegration tablet and its preparing process |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7268110 Agents for preventing and treating thrombocytopenia |
| 09/11/2007 | US7267817 Administering mixture of red blood cells and hemoglobin solution |
| 09/11/2007 | CA2310536C Erythropoietin derivatives |
| 09/11/2007 | CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 09/11/2007 | CA2124690C Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| 09/07/2007 | WO2007100435A2 Use of dha and ara in the preparation of a composition for the prevention or treatment of anemia |
| 09/07/2007 | WO2007100098A1 Multimer of extracellular domain of cell surface functional molecule |
| 09/07/2007 | WO2007099652A1 Pharmaceutical composition for treatment of blood clotting disorder |
| 09/07/2007 | WO2007070816A3 Thiophene derivatives as factor xia inhibitors |
| 09/07/2007 | WO2007009963A1 Substituted amides, their preparation and their use as pharmaceuticals |